These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 1914195)

  • 1. Plasma renin activity and plasma prorenin assays.
    Sealey JE
    Clin Chem; 1991 Oct; 37(10 Pt 2):1811-9. PubMed ID: 1914195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma prorenin in normal, hypertensive, and anephric subjects and its effect on renin measurements.
    Sealey JE; Moon C; Laragh JH; Atlas SA
    Circ Res; 1977 May; 40(5 Suppl 1):I41-5. PubMed ID: 870230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and measurement of plasma prorenin in the rat.
    Ioannou P; Loh AY; Osmond DH
    Can J Physiol Pharmacol; 1991 Sep; 69(9):1331-40. PubMed ID: 1756434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animals.
    Osmond DH; Cooper RM
    Can J Physiol Pharmacol; 1978 Oct; 56(5):792-805. PubMed ID: 709420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives.
    Derkx FH; Steunkel C; Schalekamp MP; Visser W; Huisveld IH; Schalekamp MA
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1008-15. PubMed ID: 3528208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peculiarities of plasma "prorenin" measurements in man, dog, and rat, and their theoretical implications.
    Osmond DH; Wilczynski EA; Loh AY
    Clin Exp Hypertens A; 1982; 4(11-12):2213-30. PubMed ID: 6756692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of active, total and inactive renin (prorenin), angiotensin I and angiotensinogen in carbon tetrachloride-treated rats.
    Cruz C; Ibarra-Rubio ME; Pedraza-Chaverrí J
    Clin Exp Pharmacol Physiol; 1993 Feb; 20(2):83-8. PubMed ID: 8443978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of augmented Hageman factor (Factor XII) titers on the cryoactivation of plasma prorenin in women using oral contraceptive agents.
    Gordon EM; Douglas J; Ratnoff OD
    J Clin Invest; 1983 Nov; 72(5):1833-8. PubMed ID: 6355187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin and renin inhibition in anephric man.
    Opsahl JA; Smith KL; Murray RD; Abraham PA; Katz SA
    Clin Exp Hypertens; 1993 Mar; 15(2):289-306. PubMed ID: 8467318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects.
    Sealey JE; Moon C; Laragh JH; Alderman M
    Am J Med; 1976 Nov; 61(5):731-8. PubMed ID: 10728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin substrate (angiotensinogen) preparations in the determination of prorenin and renin: evidence for extrarenal plasma prorenin and its renal "convertase".
    Purdon AD; Loh AY; Osmond DH
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2319-28. PubMed ID: 3329567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prorenin in humans and dogs. Species differences and further evidence of a systemic activation cascade.
    Wilczynski EA; Osmond DH
    Hypertension; 1983; 5(3):277-85. PubMed ID: 6341216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between active renin concentration and plasma renin activity in Type 1 diabetes.
    Valabhji J; Donovan J; Kyd PA; Schachter M; Elkeles RS
    Diabet Med; 2001 Jun; 18(6):451-8. PubMed ID: 11472463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the measurement of inactive renin in rat plasma: activation by trypsin generates interfering tetradecapeptide-like material and destroys angiotensinogen.
    Johannessen A; Nielsen AH; Jacobsen J; Poulsen K
    J Hypertens; 1989 May; 7(5):395-402. PubMed ID: 2671159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in the clinical study of the renin system. Reference values and conditions of validity].
    Plouin PF; Chatellier G; Guyene TT; Vincent N; Corvol P
    Presse Med; 1989 May; 18(18):917-21. PubMed ID: 2524779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of plasma renin activity.
    Barnes SC
    Methods Mol Biol; 2013; 1065():235-44. PubMed ID: 23996368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat renal and plasma prorenin are activated in vitro by different mechanisms.
    Vincent PA; De Vito E
    Hypertension; 1999 Sep; 34(3):520-4. PubMed ID: 10489404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high-performance liquid chromatography on plasma angiotensin II measurements in treated and untreated normotensive and hypertensive patients.
    Bragat AC; Blumenfeld J; Sealey JE
    J Hypertens; 1997 May; 15(5):459-65. PubMed ID: 9169997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measurement of plasma renin activity.
    Cawood ML
    Methods Mol Biol; 2006; 324():187-96. PubMed ID: 16761379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.